glp 1 agonist list of drugs America's Poison Centers How GLP-1 medications are transforming

Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR

The FDA approved sitagliptin, the first DPP-4i on the market, in 2006 and shortly after, numerous additional DPP-4i received market clearance

[DOI] [PubMed] [Google Scholar] 244.Riddle M.C., et al

Although there is no current evidence that gut neuropeptides or GLP-1 are implicated in the pathogenesis of IIH, these studies do highlight the therapeutic potential for GLP-1 receptor agonist in the management of IIH

Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors

Beinaglutide reduces weight, controls inflammation, and is cleared by the kidneys with fewer side effects [2]